|
|
|
Çѱ¹³ë¹ÙƼ½º½ÃÇÁ·Î¹ÙÀÌÁ¡ÀÌÇöŹ¾× Novartis Ciprobay Otic Susp.
|
Àü¹®ÀǾàÇ° | ±Þ¿©
|
|
¼öÀÔÀǾàÇ°
|
|
|
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàÇ° ÀÎÅÍ³Ý ÆǸŸ¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
¾à°£ÀÇ Á¡¼ºÀ» Áö´Ñ ¹é»ö ¶Ç´Â ¹Ì¹é»öÀÇ ºÒÅõ¸íÇÑ ÇöŹ¾×À¸·Î ÃÊ»ê ³¿»õ°¡ ³² |
|
|
|
|
|
Á¦Á¶È¸»ç |
Çѱ¹³ë¹ÙƼ½º(ÁÖ)
|
ÆǸÅȸ»ç |
Çѱ¹³ë¹ÙƼ½º(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(1999.10.01)
|
BIT ¾àÈ¿ºÐ·ù |
Ear anti-infectives/ with steroides
|
º¹ÁöºÎºÐ·ù |
132[À̺ñ°ú¿ëÁ¦ ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
653603241 \8,766 ¿ø/10mL/º´(2024.07.01)(ÇöÀç¾à°¡)\8,770 ¿ø/10mL/º´(2021.09.01) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
Hydrocortisone and antiinfectives / S02CA03 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
|
÷°¡Á¦ |
º¥Áú¾ËÄÚ¿Ã,
ºùÃÊ»ê,
¿°È³ªÆ®·ý,
Á¤Á¦¼ö,
Ãʻ곪Ʈ·ý »ï¼öȹ°,
Æ÷½ºÆ÷¸®Æù90H,
Æú¸®ºñ´Ò¾ËÄÝ,
Æú¸®¼Ò¸£º£ÀÌÆ®20
|
|
|
|
|
|
|
|
|
|
Ç× ¸ñ |
³» ¿ë |
|
ºÎÀÛ¿ëºóµµ ¹× ´ëó¹ý |
[À¯·á] |
|
|
|
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-06-28 |
|
|
|
|
|
|
|
|